Home
Live Updates
Dyadics C1 Platform Selected by the Vaccine and Immunotherapy Center (VIC) at Massachusetts ... | Region : comparemela.com
Dyadic's C1 Platform Selected by the Vaccine and Immunotherapy Center ("VIC") at Massachusetts ... | Region
JUPITER, Fla., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms
Related Keywords
Massachusetts ,
United States ,
Delaware ,
Patrickj Gallagher ,
Mark Emalfarb ,
Mark Poznansky ,
Voltron Therapeutics Inc ,
Immunotherapy Center At Massachusetts ,
Us Department Of Defense Do ,
Securities Exchange ,
Immunotherapy Center ,
Dyadic International ,
Dyadic International Inc ,
Massachusetts General Hospital ,
Voltron Therapeutics ,
Self Assembling Vaccine ,
Chief Executive ,
Massachusetts General ,
Emerging Infectious ,
Lassa Fever ,
Securities Act ,
Securities Exchange Act ,
Region ,
comparemela.com © 2020. All Rights Reserved.